Critical Path Institute
visit https://www.bayer.com/en/us/ marana. BD
The global medical technology company known as BD announced in April that it will construct a $65 million facility in Tucson that will be a hub for the company’s supply chain, serving as a final-stage manufacturing and sterilization center. The 120,000 square-foot facility will be built on approximately 32 acres at the northeast corner of Valencia and Kolb Road and is planned to open in mid2022. BD plans to add approximately 40 new jobs, including engineers, scientists, quality control specialists and other skilled talent. Sun Corridor Inc., the region’s economic engine, projects that BD’s investment will have a $122 million economic impact on the region over the next decade. BD operates more than 90 medical device and health care technology manufacturing and sterilization facilities globally and has a track record of sustainable operations. This facility will be one of the first in the world with an original design that will meet or exceed the most stringent environmental guidelines. “Tucson is the ideal location for critical infrastructure and was selected after a careful review of a number of alternative locations in the southwestern U.S. and Mexico,” said Alexandre Conroy, BD’s executive VP, integrated supwww.BizTucson.com
Edmund Optics
ply chain. “Arizona’s favorable business climate, the strength of its workforce and Tucson’s centrality to other parts of BD’s supply chain were key factors in the decision.” Critical Path Institute
The non-profit C-Path brings together patient groups, academic institutions, the pharmaceutical industry and regulatory agencies from around the world to improve public health. Together, these stakeholders work to identify or create tools that can accelerate the medical product development and regulatory review process. C-Path manages collaborative teams and programs (currently 24), in which stakeholders combine intellectual and financial resources to generate solutions that facilitate the development of safe and effective medical products. C-Path’s programs focus on specific areas, patient populations, therapeutic indications or drug development and data sharing challenges. These include Alzheimer’s disease, Parkinson’s disease, Type 1 diabetes, rare/orphan diseases, neonatology data science, modelinformed drug development and drug safety testing. Founded by Dr. Raymond L. Woosley in 2005, C-Path opened in Tucson with six employees. Today, more than 100 scientists, pharmaceutical industry leaders and medical professionals are on staff at C-Path and make up its board. The institute’s global presence
Emagine Solutions Technology
includes a European headquarters in Dublin. Edmund Optics
Edmund Optics is a leading supplier of optics, imaging and photonics technology that has served a variety of markets including life sciences, biomedical, industrial inspection, semiconductor, research and development and defense since 1942. Edmund designs and manufactures a wide array of optical components, multi-element lenses, imaging systems, and optomechanical equipment, while supporting applications with volume production of stock and custom products. In February, Edmund opened an assembly and advanced design facility in Tucson, where the company has had a presence since 1998. The 21,225 square-foot facility expansion supports advanced design efforts and high-volume manufacturing services, including cleanroom assembly and incoming inspection with numerous testing capabilities such as MTF, straylight, thermal cycle, shock and vibration. “This new facility will allow Edmund Optics to build a larger collaborative partnership with Arizona Optics Initiative and the Arizona Technology Council,” said Robert Edmund, CEO and board chairman. “It solidifies our commitment to Tucson and AZTEC Optics Valley initiatives.” continued on page 42 >>> Fall 2021
>>>
BizTucson 41
